Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6819936 | Psychosomatics | 2018 | 34 Pages |
Abstract
Although there have been a number of randomized clinical trials of patients with CHD that assessed anxiety, in most cases anxiety was a secondary outcome, and only one-third found that symptoms of anxiety were reduced with treatment. Future studies need to target anxious patients and evaluate the effects of treatment on anxiety and relevant clinical endpoints.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Julia M. B.S., Gregory L. Ph.D., James A. Ph.D.,